Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Polomar Health ServicesPMHS 37 Net Cash per Share is $-0.06 as of Jun. 2026. GuruFocus rates PMHS with a GF Score™ of 37/100 and a GF Value™ of $23.41 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 136 Healthcare Providers & Services companies, Polomar Health Services ranks worse than 735293.38% on this metric.
The historical rank and industry rank for Polomar Health Services's Net Cash per Share or its related term are showing as below:
During the past 7 years, the highest Price-to-Net-Cash Ratio of Polomar Health Services was 1290.00. The lowest was 1290.00. And the median was 1290.00.
PMHS's Price-to-Net-Cash is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 7.85 * Ranked among companies with meaningful Price-to-Net-Cash only.
Polomar Health Services (OTCPK:PMHS) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Polomar Health Services Net Cash per Share Related Terms
Polomar Health Services Net Cash per Share Historical Data
* Premium members only.
The historical data trend for Polomar Health Services's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMHS vs HEWA, BLMH, RDGT: Net Cash per Share Comparison
For the Pharmaceutical Retailers subindustry, Polomar Health Services's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polomar Health Services Price-to-Net-Cash vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Polomar Health Services's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Polomar Health Services's Price-to-Net-Cash falls into.
Polomar Health Services Net Cash per Share Calculation
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Polomar Health Services's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polomar Health Services (PMHS) has a Net Cash per Share of $-0.06 as of Jun. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Polomar Health Services and its competitors. According to the industry distribution chart, Polomar Health Services ranks #999999 out of 136 companies in the Healthcare Providers & Services industry.
Is Polomar Health Services' Net Cash per Share too high?
Polomar Health Services' current Net Cash per Share is $-0.06. Based on the distribution chart, Polomar Health Services ranks #999999 out of 136 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Polomar Health Services has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Polomar Health Services' Net Cash per Share compare to HEWA and BLMH?
According to the Healthcare Providers & Services industry distribution chart, Polomar Health Services ranks #999999 out of 136 companies for Net Cash per Share. This places Polomar Health Services in the lower half of its industry. The industry median Net Cash per Share is 7.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Healthcare Providers & Services company?
The median Net Cash per Share among Healthcare Providers & Services companies is 7.85, based on 136 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Polomar Health Services and its competitors. For the Healthcare Providers & Services industry, the median Net Cash per Share is 7.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polomar Health Services's current Net Cash per Share is $-0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polomar Health Services stock overvalued right now?
Based on GuruFocus' analysis, Polomar Health Services (PMHS) is currently considered Possible Value Trap. The stock's GF Value™ is $23.41, compared to a current price of $0.20 — trading 99.1% below its estimated fair value. The current Net Cash per Share is $-0.06. Polomar Health Services' overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Polomar Health Services (PMHS), the current Net Cash per Share is $-0.06 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Polomar Health Services (PMHS) Overvalued in 2026?
Based on GuruFocus' analysis, Polomar Health Services stock appears to be undervalued.
The current stock price of $0.20 is trading 99.1% below its estimated GF Value™ of $23.41.
GuruFocus considers Polomar Health Services to be Possible Value Trap.
Key valuation signals for PMHS:
Net Cash per Share: $-0.06
GF Value™: $23.41 vs. price of $0.20 (99.1% below fair value)
No single metric tells the full story. See the PMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Polomar Health Services Inc is a U.S.-based healthcare company specializing in retail compounding pharmacy services and prescription fulfillment for telehealth platforms. It is also licensed as a Special Sterile Compounding Pharmacy, permit #PH35277, which authorizes the licensed entity to dispense injectable and other sterile compounds (eye drops, infused therapeutics) upon receipt of a valid prescription. The firm is presently licensed and authorized to fulfill and deliver compounded prescribed medications in 28 states.
37GF Score
Get the complete analysis for PMHS
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMHS has been successfully added to your 
